Skip to Main Content
Back to News

Lobbying Update: $70,000 of GLAUKOS CORPORATION lobbying was just disclosed

None

$70,000 of GLAUKOS CORPORATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Tax Relief for American Families and Workers Act of 2023, H.R.7024 H.R. 8702/S. 4532 Improving Seniors Timely Access to Care Act of 2024 H.R. 972/ S. 312 Outpatient Surgery Quality and Access Act of 2023 Legislation regarding FDA regulation of combination products"

You can find more data on corporate lobbying on Quiver Quantitative.

GKOS Insider Trading Activity

GKOS insiders have traded $GKOS stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $GKOS stock by insiders over the last 6 months:

  • AIMEE S WEISNER sold 25,000 shares for an estimated $3,000,000
  • GILBERT H KLIMAN has made 0 purchases and 4 sales selling 15,000 shares for an estimated $2,182,820.
  • JOSEPH E GILLIAM (PRESIDENT & COO) has made 0 purchases and 5 sales selling 10,603 shares for an estimated $1,461,663.
  • MARC STAPLEY has made 0 purchases and 4 sales selling 6,250 shares for an estimated $787,086.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GKOS Hedge Fund Activity

We have seen 173 institutional investors add shares of GKOS stock to their portfolio, and 118 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles